Ass. Prof. Dr. Jens Hartmann

Harm, S.; Lohner, K.; Fichtinger, U.; Schildböck, C.; Zottl, J.; Hartmann, J. (2019). Blood Compatibility—An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application. International Journal of Molecular Sciences, Volume 20 Issue 21 10.3390/ijms20215426: 10.3390/ijms20215426

Harm, S.; Schildböck, C.; Hartmann, J. (2019). Cytokine removal in extracorporeal blood purification: An in vitro study. Blood Purification, in press: 1-11

Gubensek, J.; Strobl, K.; Harm, S.; Weiss, R.; Eichhorn, T.; Buturovic-Ponikvar, J.; Weber, V.; Hartmann, J. (2018). Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup. PLoS ONE, 13(6):e0199204: doi: 10.1371/journal.pone.0199204

Harm, S.; Schildböck, C.; Hartmann, J. (2018). Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification. PLoS One, Jan 24;13(1): 10.1371/journal.pone.0191741

Eichhorn, T.; Hartmann, J.; Harm, S.; Linsberger, I.; König, F.; Valicek, G.; Miestinger, G.; Hörmann, C.; Weber, V. (2017). Clearance of selected cytokines with continuous veno-venous hemodialysis using Ultraflux EMiC2 versus Ultraflux AV1000S. Blood Purification, 44(4): 260-266

Hartmann, J.; Harm, S. (2017). A new integrated technique for the supportive treatment of sepsis. International Journal of Artificial Organs, 40(1): 4-8

Hartmann, J.; Harm, S. (2017). Removal of bile acids by extracorporeal therapies: an in vitro study. International Journal of Artificial Organs, doi: 10.5301/ijao.5000643: doi: 10.5301/ijao.5000643

Strobl, K.; Harm, S.; Weber, V.; Hartmann, J. (2017). The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. International Journal of Artificial Organs, 40(1): 15-21

Harm, S.; Hartmann, J. (2017). Removal of stabilizers from human serum albumin by nanostructured adsorbents. BioNanoMed Congress, March 2017, Krems, Austria

Hartmann, J.; Harm, S. (2017). Cytokine induction in human blood by fractionated bacterial lysates. BioNanoMed Congress, March 2017, Krems, Austria

Harm, S.; Gabor, F.; Hartmann, J. (2016). Low-Dose Polymyxin: an Option for Therapy of Gram-Negative Sepsis. Innate Immunity, 2016: 274-283

Harm, S.; Gruber, A.; Gabor, F.; Hartmann, J. (2016). Adsorption of Selected Antibiotics to Resins in Extracorporeal Blood Purification. Blood Purification, 2016(41): 55-63

Harm, S.; Hartmann, J. (2016). Low-Dose Polymyxin: An Option for Therapy of Gram-Negative Sepsis. Innate Immunity, March 2016. DOI: 10.1177/17534259

Harm, S.; Hartmann, J. (2016). Polymyxin-Coated Nanostructured Materials: An Option for Sepsis Treatment. Journal of Nanomaterials & Molecular Nanotechnology, 10.4172/2324-8777.S4-003

Harm, S.; Gabor, F.; Hartmann, J. (2015). Characterization of Adsorbents for Cytokine Removal from Blood in an In Vitro Model. Journal of Immunology Research, Vol. 2015, Article ID 484736

Harm, S.; Gabor, F.; Hartmann, J. (2015). In vitro characterization of a new adsorbent for cytokines in extracorporeal blood purification. Shock, 44 Suppl 2:9

Hartmann, J. (2015). Endotoxins in Extracorporeal Blood Purification: Are AMPs the Solution? 5. International Meeting on Antimicrobial Peptides

Harm S., Falkenhagen D., Hartmann J. (2014). Endotoxin adsorbents in extracorporeal blood purification: Do they fulfill expectations? The International journal of artificial organs, 04/2014, 37(3), DOI:10.5301/ijao.5000304: 222

Harm S.; Falkenhagen D.; Hartmann J. (2014). Endotoxin Adsorbents in Extracorporeal Blood Purification – Do They Fulfill The Expectations? Int J Art Org, Vol. 37, Issue 3: 222-232

Harm, S.; Falkenhagen, D.; Hartmann, J. (2014). Pore size – a key property for selective toxin removal in blood purification. Int J Art Org, DOI:10.5301/ijao.5000354: 668-678